New York put together a draft plan for how to spent $600 million over 11 years to foster stem-cell research and is seeking input through June 20. You can read the plan and leave comments at the link above.
Below, I’ll provide the budget breakdown for the plans for New York and the California Institute of Regenerative Medicine.
Here a clip from the press release:
“According to the draft Strategic Plan, the state will utilize the
funding to support innovative basic, translational and clinical research that builds on the potential of stem cells to detect, treat and cure human diseases. New York’s legislation creating the stem cell research initiative expressly forbids the use of state funding for human reproductive cloning.”
The plan was developed over 6 months by staff and board members of New York State Stem Cell Science (a group within the state’s health department) plus other experts. It gives ranges of spending over its first 5 years. Of the $300 million to be spent over this time, research will get 65-80% of the funds, scientific training 4-10%, infrastructure development 10-15%, administration and consideration of societal, ethical, and legal issues will both receive 3 to 5%.
For comparison, the California Institute of Regenerative Medicine issued a strategic plan in 2006, which also forbids reproductive cloning. Its budget is complicated because the funding comes from bonds with provisions for issuing loans, and the $3 billion budget assumes $52 million over ten years in capitalized interest. Overall, the budget estimates that 3% of the $3 billion funds over ten years will go for general administration, 3% for grants administration, 1% for issuing bonds and litigation, 9% for facilities, and 82% for research. The $2,377.5 million allocated for research includes funds for a journal and web portal ($1.9 million), public outreach ($4.5 million), and assessing impacts on society and the economy ($27.8 million), with the vast majority of funds aimed at grants for scientists and scientific training.
Because of the federal funding ban, US states are emerging as independent entities within the stem-cell research enterprise. Our related content includes a news feature on what states are doing to coordinate their efforts, a scientist’s perspective on how the fragmented funding environment strains the scientific enterprise, and a scientist’s perspective on shepherding international efforts to advance stem cell research.